Swiss Parenterals

Activity by year

202420252026

Acquisition

Nov 25, 2025ACQUISITIONIndia$51.0M
Eris Lifesciences to acquire remaining 30% stake in Swiss Parenterals
Eris Lifesciences agreed to acquire the balance 30% stake in Swiss Parenterals for ₹423.3 crore via a share swap, making it a wholly-owned subsidiary. The deal is expected to close before March 31, 2026.
Eris Lifesciences acquirer Swiss Parenterals target #Medical Devices indiainfoline.com
Feb 13, 2024ACQUISITIONGujarat, India$77.0M
Eris Lifesciences acquires 51% stake in Swiss Parenterals for ₹637.5 crore
Eris Lifesciences has acquired a 51% equity stake in Swiss Parenterals Ltd for ₹637.5 crore, with the promoter group acquiring an additional 19%, expanding into sterile injectables and RoW export markets.
Eris Lifesciences acquirer Swiss Parenterals target #Medical Devices financialexpress.com

Acquired by

Loading…

Swiss Parenterals: plants, expansions, contracts and acquisitions · Endata